Leigh MacMillan

March 28, 2019

Drug interaction causes hypotension

A muscle relaxing-drug and inhibitors of the metabolic enzyme CYP1A2 interact to cause severely low blood pressure and should not be co-prescribed, Vanderbilt investigators caution.

By Leigh MacMillan
March 28, 2019

Cancer prevention drug also disables H. pylori bacterium

A medicine currently being tested as a chemoprevention agent for multiple types of cancer has more than one trick in its bag when it comes to preventing stomach cancer, Vanderbilt researchers have discovered.

By Leigh MacMillan
Longtime colleagues and friends Curt Thorne, left, and Terry Burke enjoyed sailing together.
March 28, 2019

Bladder cancer research fund honors mentor’s lasting influence

The Terry Burke Fund for Bladder Cancer Research at Vanderbilt-Ingram Cancer Center is supporting a range of discovery research aimed at improving outcomes for bladder cancer patients, and it is helping train the next generation of bladder cancer physician-scientists.

By Leigh MacMillan
March 21, 2019

Cancer researcher Kimberly Dahlman is too busy to run in the Boston Marathon, but she’s doing it anyway — for her daughter

“Even though I felt like I was already over-committed, I knew that I needed to do this”

By Leigh MacMillan
March 21, 2019

Brain injury expert Francisco set for Discovery Lecture

Gerard Francisco, MD, renowned for his clinical expertise and research in the field of brain injury, stroke rehabilitation and spasticity management, will deliver the next Flexner Discovery Lecture on Thursday, March 28.

By Leigh MacMillan
March 14, 2019

Exploring the brain’s white matter

New comprehensive functional MRI measurements point to the need to update models for assessing brain white matter activity and physiology.

By Leigh MacMillan
March 7, 2019

Vanderbilt mourns cancer researcher Stephen Hann

Stephen Hann, PhD, professor of Cell and Developmental Biology, died Feb. 27. He was 67.
By Leigh MacMillan
February 28, 2019

Lighting up colorectal cancer

A nanobeacon imaging agent that binds specifically to colorectal cancer cells may aid the early detection of cancer during colonoscopy.
By Leigh MacMillan
February 28, 2019

Protein loss promotes cell migration

The protein kinase STK17A plays a novel role in epithelial cells and its loss may contribute to colorectal cancer invasion and metastasis, Vanderbilt researchers report.
By Leigh MacMillan
February 28, 2019

Novel DNA repair mechanism preserves genome integrity: study

Biochemistry investigators at Vanderbilt have discovered a new DNA repair mechanism that prevents gene mutations during DNA replication.
By Leigh MacMillan
February 28, 2019

Evans set for next Discovery Lecture

Ronald Evans, PhD, renowned for his discoveries of nuclear hormone receptors and how they work, will deliver the next Flexner Discovery Lecture on Thursday, March 7.
By Leigh MacMillan
February 21, 2019

Discovery points to new cancer immunotherapy option

An international team involving Vanderbilt researchers has discovered that a new “checkpoint” protein on immune system cells is active in tumors, and that blocking it — in combination with other treatments — is a successful therapeutic approach in mouse models of cancer.
By Leigh MacMillan